Shareholding disclosure
MindMaze Therapeutics Holding SA
Declared position
36.975%
Threshold
Crossed downwards
Timeline
Published
04.02.2026
Transaction
02.02.2026
Voting rights breakdown
Voting rights acquired4.087%
Voting rights sold36.975%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
ZA01-000000000RLY2
Beneficial owner
MindMaze Therapeutics Holding SA
Declared address
MindMaze Therapeutics Holding SA, Genève, CH
Crossing up of a sale threshold following the recalculation of positions related to equity derivative with actual delivery pursuant to Art. 14 FMIO-FINMA and Art. 4 of Disclosure Office Notice II/13.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open